{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:04:32Z","timestamp":1767917072424,"version":"3.49.0"},"reference-count":42,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s278169","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T22:55:44Z","timestamp":1610060144000},"page":"79-91","source":"Crossref","is-referenced-by-count":12,"title":["Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial"],"prefix":"10.2147","volume":"Volume 15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1339-5123","authenticated-orcid":true,"given":"Jay S","family":"Pepose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7496-7287","authenticated-orcid":true,"given":"Paul J","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey B","family":"DuBiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Smyth-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0418-0657","authenticated-orcid":true,"given":"Sayoko E","family":"Moroi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan R","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina P","family":"Sooch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4723-9054","authenticated-orcid":true,"given":"Reda M","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-1088","authenticated-orcid":true,"given":"Konstantinos","family":"Charizanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth A","family":"Klapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arin T","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3471-6731","authenticated-orcid":true,"given":"Jonah E","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliot S","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1390-2532","authenticated-orcid":true,"given":"Paul M","family":"Karpecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2571-4726","authenticated-orcid":true,"given":"Charles B","family":"Slonim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marguerite B","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.ophtha.2018.04.013","volume":"125","author":"Fricke","year":"2018","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaophthalmol.2016.4587","volume":"135","author":"Eydelman","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1167\/iovs.16-21219","volume":"58","author":"Kimlin","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jcrs.2010.11.032","volume":"37","author":"de Vries","year":"2011","journal-title":"J Cataract Refract Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.08.009","author":"Masket","year":"2020","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4140\/TCP.n.2018.432","volume":"33","author":"Marshall","year":"2018","journal-title":"Consult Pharm J Am Soc Consult Pharm"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.2174\/092986707780362853","volume":"14","author":"Antonelli-Incalzi","year":"2007","journal-title":"Curr Med Chem"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","volume":"62","author":"Giovannitti","year":"2015","journal-title":"Anesth Prog"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","volume":"109","author":"Sommer","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/S0161-6420(92)31774-9","volume":"99","author":"Klein","year":"1992","journal-title":"Ophthalmology"},{"key":"ref12","first-page":"133","volume":"35","author":"Shiose","year":"1991","journal-title":"Jpn J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/jop.2006.0102","volume":"23","author":"Kiel","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/eye.1989.71","volume":"3","author":"McAuliffe-Curtin","year":"1989","journal-title":"Eye"},{"key":"ref15","unstructured":"Ocuphire Pharma, Inc. Double-masked parallel evaluation of the safety and efficacy of phentolamine mesylate ophthalmic solution in subjects with severe night vision disturbances. clinicaltrials.gov; 2019. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01703559. Accessed June 22, 2020."},{"key":"ref16","unstructured":"Associations of presbyopia with vision-targeted health-related quality of life | ophthalmology | JAMA ophthalmology | JAMA network; 2020. Available from: https:\/\/jamanetwork-com.proxy.lib.umich.edu\/journals\/jamaophthalmology\/fullarticle\/415846."},{"key":"ref17","unstructured":"Charman WNTJ The depth-of-focus of the human eye for Snellen letters. - abstract - Europe PMC; 2020. Available from: https:\/\/europepmc.org\/article\/med\/1111286."},{"key":"ref18","first-page":"847","volume":"52","author":"Dexl","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/08820538.2019.1586966","volume":"34","author":"Park","year":"2019","journal-title":"Semin Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"5656","DOI":"10.1167\/iovs.16-20008","volume":"57","author":"Xu","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jcrs.2011.11.029","volume":"38","author":"Brooks","year":"2012","journal-title":"J Cataract Refract Surg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.ophtha.2008.12.038","volume":"116","author":"Schallhorn","year":"2009","journal-title":"Ophthalmology"},{"key":"ref23","doi-asserted-by":"publisher","volume-title":"Management of Complications in Refractive Surgery","year":"2018","DOI":"10.1007\/978-3-319-60561-6_21"},{"key":"ref24","volume-title":"Management of Complications in Refractive Surgery","year":"2018"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.clae.2010.04.006","volume":"33","author":"Romero-Jim\u00e9nez","year":"2010","journal-title":"Contact Lens Anterior Eye"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/archopht.116.8.1053","volume":"116","author":"Mart\u00ednez","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0014-4835(85)90158-7","volume":"40","author":"Yoshitomi","year":"1985","journal-title":"Exp Eye Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijpsycho.2003.12.005","volume":"52","author":"Steinhauer","year":"2004","journal-title":"Int J Psychophysiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1124\/jpet.300.2.521","volume":"300","author":"Yu","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3109\/02713683.2014.946519","volume":"40","author":"Sharpe","year":"2015","journal-title":"Curr Eye Res"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126(4):498\u2013505. doi:10.1016\/s0002-9394(98)00272-4.","DOI":"10.1016\/S0002-9394(98)00272-4"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1111\/aos.12082","volume":"91","author":"Kim","year":"2013","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2147\/OPTH.S3182","volume":"2","author":"Iester","year":"2008","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00061198-200108000-00012","volume":"10","author":"Petounis","year":"2001","journal-title":"J Glaucoma"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J"},{"key":"ref37","unstructured":"Ocuphire Pharma, Inc. Single dose study of phentolamine mesylate eye drops in patients with severe night vision disturbances. clinicaltrials.gov; 2019. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04004507. Accessed June 22, 2020."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1136\/bjo.87.11.1387","volume":"87","author":"Wood","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"ref39","unstructured":"Food and Drug Administration. Determination that REV\u2013EYES (dapiprazole hydrochloride ophthalmic solution), 0.5%, was not withdrawn from sale for reasons of safety or effectiveness. Fed Reg. 2013;78(92):27971."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1475-1313.1989.tb00835.x","volume":"9","author":"Shah","year":"1989","journal-title":"Ophthal Physiol Opt J Br Coll Ophthal Opt Optom"},{"key":"ref41","first-page":"466","volume":"105","author":"Roberts","year":"1952","journal-title":"J Pharmacol Exp Ther"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e0140601","DOI":"10.1371\/journal.pone.0140601","volume":"10","author":"Oddone","year":"2015","journal-title":"PLoS One"}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=65527","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=65527","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T22:55:55Z","timestamp":1610060155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/phentolamine-mesylate-ophthalmic-solution-provides-lasting-pupil-modul-peer-reviewed-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":42,"URL":"https:\/\/doi.org\/10.2147\/opth.s278169","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}